Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Judges Scientific ( (GB:JDG) ) has issued an announcement.
Judges Scientific plc announced a ‘Bed and ISA’ transaction involving CEO David Cicurel and his spouse, where they sold and immediately repurchased a total of 625 ordinary shares into their ISAs. This transaction did not alter Cicurel’s total beneficial interest in the company, which remains at 544,369 ordinary shares. The move reflects a strategic financial decision, maintaining the company’s operational stability and shareholder interests.
The most recent analyst rating on (GB:JDG) stock is a Buy with a £12230.00 price target. To see the full list of analyst forecasts on Judges Scientific stock, see the GB:JDG Stock Forecast page.
Spark’s Take on GB:JDG Stock
According to Spark, TipRanks’ AI Analyst, GB:JDG is a Neutral.
The overall stock score reflects strong financial performance but is tempered by technical analysis indicators suggesting a bearish trend and a high P/E ratio. Corporate events show management confidence, but market challenges, particularly in the US, present risks.
To see Spark’s full report on GB:JDG stock, click here.
More about Judges Scientific
Judges Scientific plc is a group specializing in acquiring and developing companies within the scientific instrument sector. Since 2005, the company has acquired 25 businesses, primarily UK-based, with products sold globally to markets such as higher education, scientific research, manufacturing, and regulatory authorities. Known for its innovation and export excellence, Judges Scientific operates in niche markets with strong growth fundamentals and sustainable profit generation.
Average Trading Volume: 19,873
Technical Sentiment Signal: Sell
Current Market Cap: £432.1M
For detailed information about JDG stock, go to TipRanks’ Stock Analysis page.